ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2019

Prediction of Progression-Free Survival in Patients With Advanced, Well-Differentiated, Neuroendocrine Tumors Being Treated With a Somatostatin Analog: The GETNE-TRASGU Study.

Alberto Carmona-Bayonas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.